Research Article

Prevalence and Antimicrobial Susceptibility of Bacterial Uropathogens Isolated from Pediatric Patients at Yekatit 12 Hospital Medical College, Addis Ababa, Ethiopia

Table 4

The number and percent of resistant strains of Gram-negative uropathogens among pediatric patients at Yekatit 12 Hospital Medical College, Addis Ababa, Ethiopia, 2014.

Bacteria isolatedTotal no.Antimicrobial agents tested
CIPCXMGNNASXTFAMPCNORCTXCAZ
No. (%)No. (%)No. (%)No. (%)No. (%)No. (%)No. (%)No. (%)No. (%)No. (%)No. (%)

E. coli286 (21.4)9 (32.1)8 (28.6)9 (32.1)19 (67.9)5 (17.9)11 (39.3)8 (28.6)7 (25.0)9 (32.1)9 (32.1)
Klebsiella spp.175 (29.4)15 (88.2)14 (82.4)9 (52.9)15 (88.2)5 (29.4)12 (70.6)10 (58.8)6 (35.3)15 (88.2)15 (88.2)
Acinetobacter spp.1001 (100)1 (100)1 (100)01 (100)0000
Proteus spp.3000003 (100)00000
Total4911 (22.5)24 (48.9)23 (46.9)19 (38.7)35 (71.4)13 (26.5)24 (48.9)18 (36.7)13 (26.5)24 (48.9)24 (48.9)

AMP: augmentin (30 μg); NOR: norfloxacin (30 μg); GN: gentamicin (30 μg); CIP: ciprofloxacin (5 μg); NA: nalidixic acid (30 μg); F: nitrofurantoin (30 μg); CAZ: ceftazidime (30 μg); CTX: cefotaxim (30 μg); C: chloramphenicol (30 μg); SXT: trimethoprim-sulfamethoxazole (1.25/23.75 μg); CXM: cefuroxime (30 μg).